OQROGet OQRO Pro
Insider trade

Edgewise Therapeutics (EWTX)CEO sold ~$70K

Kevin Koch, CEO at Edgewise Therapeutics, sold ~$70K of Edgewise Therapeutics shares.

~$70K
Approx. value · 4,276 sh @ $16.45
21K
Holds after · shares reported
Traded
May 2, 2025
Filed
May 8, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 7, 2025Insider · 2 peopleInsiders: 2 sales (~$9K)
  2. Apr 3, 2025Insider · 2 peopleInsiders: 4 purchases (~$20.0M)
  3. May 2, 2025 · this disclosureInsiderCEO sold ~$70K of EWTX shares in the open market

What came next

  1. May 2, 2025Insider · 5 peopleInsiders: 5 sales (~$192K)
  2. Aug 12, 2025Insider · 6 peopleInsiders: 6 sales (~$251K)
  3. Aug 26, 2025InsiderDirector sold ~$1.46M of EWTX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Edgewise Therapeutics

For Edgewise Therapeutics, OQRO holds 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EWTX page.

Other recent filings by Kevin Koch, President and CEO

The full history of Kevin Koch, President and CEO is on the profile page.

How this filing works

Other disclosures at Edgewise Therapeutics

Everything OQRO holds on this company is on its EWTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data